Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of intravenous peramivir plus standard of care versus placebo plus standard of care in hospitalized patients with serious influenza
2009-012367-34Phase 3Terminated
- Sponsor
- BioCryst Pharmaceuticals, Inc.
- Start
- Sep 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in influenza comparing Peramivir plus standard of care with Placebo plus standard of care (2 arms). Primary endpoint: Time to clinical resolution. Started Sep 2009; status: terminated.
02
Drugs
peramivir
03
Conditions
influenza
Beyond the preview
Go deeper on 2009-012367-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012367-34.